Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Allergy Clin Immunol ; 135(4): 936-945.e4, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25445829

RESUMO

BACKGROUND: Skin barrier integrity requires a highly coordinated molecular system involving the structural protein filaggrin (FLG). Mutational loss of the skin barrier protein FLG predisposes subjects to the development of atopic dermatitis (AD). OBJECTIVE: We sought to determine the role of sirtuin 1 (SIRT1) in skin barrier function, FLG expression, and development of AD. METHODS: Skin histology of mice with skin-specific SIRT1 deletion and wild-type control animals was examined by using hematoxylin and eosin staining. Protein and mRNA abundance was analyzed by means of immunoblotting, immunohistochemistry, immunofluorescence, and RT-PCR. Serum antibody levels were assessed by means of ELISA. RESULTS: Here we show that FLG is regulated by the protein deacetylase SIRT1 and that SIRT1 is critical for skin barrier integrity. Epidermis-specific SIRT1 ablation causes AD-like skin lesions in mice, and mice with epidermal SIRT1 deletion are sensitive to percutaneous challenge by the protein allergen ovalbumin. In normal human keratinocytes and mouse skin SIRT1 knockdown or genetic deletion downregulates FLG, and regulation of FLG expression by SIRT1 requires the deacetylase activity of SIRT1. SIRT1 also promotes activation of the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor ligand restores FLG expression in SIRT1-inhibited cells. Compared with normal human skin, SIRT1 is downregulated in both AD and non-AD lesions. CONCLUSION: Our findings demonstrate a critical role of SIRT1 in skin barrier maintenance, open up new opportunities to use SIRT1 as a pharmacologic target, and might facilitate the development of mechanism-based agents for AD prevention and therapy.


Assuntos
Alérgenos/imunologia , Sirtuína 1/genética , Pele/imunologia , Pele/metabolismo , Alérgenos/administração & dosagem , Animais , Dermatite Atópica/genética , Dermatite Atópica/imunologia , Dermatite Atópica/metabolismo , Modelos Animais de Doenças , Epiderme/imunologia , Epiderme/metabolismo , Epiderme/patologia , Epiderme/ultraestrutura , Feminino , Proteínas Filagrinas , Deleção de Genes , Regulação da Expressão Gênica , Humanos , Imunoglobulina E/imunologia , Proteínas de Filamentos Intermediários/genética , Proteínas de Filamentos Intermediários/metabolismo , Queratinócitos/imunologia , Mastócitos/imunologia , Camundongos , Camundongos Knockout , Proteínas Proto-Oncogênicas c-akt/metabolismo , Receptores de Hidrocarboneto Arílico/metabolismo , Sirtuína 1/metabolismo , Pele/patologia , Pele/ultraestrutura
2.
J Biol Chem ; 289(52): 35806-14, 2014 Dec 26.
Artigo em Inglês | MEDLINE | ID: mdl-25378405

RESUMO

Skin cancer is the most common cancer in the United States and is mainly caused by environmental UV radiation. Reducing skin cancer incidence is becoming an urgent issue. The stress-inducible protein Sestrin2 (Sesn2) plays an important role in maintaining redox and metabolic homeostasis and their related pathologies. However, the role of Sesn2 in cancer remains unclear. Here we show that UVB radiation induces Sesn2 expression in normal human keratinocytes, mouse skin, normal human melanocytes, and melanoma cells. In addition, Sesn2 promotes AKT activation through a PTEN-dependent mechanism. Sesn2 deletion or knockdown sensitizes squamous cell carcinoma (SCC) cells to 5-fluorouracil-induced apoptosis and melanoma cells to UVB- and vemurafenib-induced apoptosis. In mice Sesn2 knockdown suppresses tumor growth from injected human SCC and melanoma cells. Last, as compared with normal skin, Sesn2 is up-regulated in both human skin SCC and melanoma. Our findings demonstrate that Sesn2 promotes AKT activation and survival in response to UVB stress and chemotherapeutics and suggest that Sesn2 is oncogenic in skin SCC and melanoma.


Assuntos
Carcinoma de Células Escamosas/patologia , Melanoma Experimental/patologia , Proteínas Nucleares/fisiologia , Proteínas Proto-Oncogênicas c-akt/metabolismo , Neoplasias Cutâneas/patologia , Animais , Antineoplásicos/farmacologia , Apoptose , Carcinoma de Células Escamosas/metabolismo , Sobrevivência Celular , Feminino , Células HeLa , Humanos , Melanoma Experimental/metabolismo , Camundongos , Camundongos Nus , Transplante de Neoplasias , Transdução de Sinais , Neoplasias Cutâneas/metabolismo , Carga Tumoral , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA